Education
About Us
Working with TipRanks
Follow Us
Arcoma AB (SE:ARCOMA)
:ARCOMA
ARCOMA Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr7.96 - kr16.40
Previous CloseN/A
Volume10.05K
Average Volume (3M)23.23K
Market Cap
kr121.34M
Enterprise Valuekr110.67M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)22.1
Beta0.33
Next Earnings
Oct 23, 2025EPS Estimate
0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding14,308,510
10 Day Avg. Volume41,231
30 Day Avg. Volume23,228
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
ARCOMA FAQ
What was Arcoma AB’s price range in the past 12 months?
Arcoma AB lowest stock price was kr7.96 and its highest was kr16.40 in the past 12 months.
What is Arcoma AB’s market cap?
Arcoma AB’s market cap is kr121.34M.
When is Arcoma AB’s upcoming earnings report date?
Arcoma AB’s upcoming earnings report date is Oct 23, 2025 which is in 55 days.
How were Arcoma AB’s earnings last quarter?
Arcoma AB released its earnings results on Aug 21, 2025. The company reported kr0 earnings per share for the quarter, missing the consensus estimate of kr0.1 by -kr0.1.
Is Arcoma AB overvalued?
According to Wall Street analysts Arcoma AB’s price is currently Overvalued.
Does Arcoma AB pay dividends?
Arcoma AB does not currently pay dividends.
What is Arcoma AB’s EPS estimate?
Arcoma AB’s EPS estimate is 0.2.
How many shares outstanding does Arcoma AB have?
Arcoma AB has 14,308,510 shares outstanding.
What happened to Arcoma AB’s price movement after its last earnings report?
Arcoma AB reported an EPS of kr0 in its last earnings report, missing expectations of kr0.1. Following the earnings report the stock price went down -8.079%.
Which hedge fund is a major shareholder of Arcoma AB?
Currently, no hedge funds are holding shares in SE:ARCOMA
Company Description
Arcoma AB
Arcoma AB develops, produces, and provides radiology solutions worldwide. It offers digital x-ray and radiography systems for radiographic applications, as well as for use in general, eneral, muscle/skeleton, thoratic, pediatric, and trauma/resus clinics. The company sells its products through OEM partners. Arcoma AB was founded in 1990 and is based in Växjö, Sweden.
Technical Analysis
Clinical Laserthermia Systems AB Class B
―
SpectraCure AB
―
Luxbright AB
―
BrainCool AB
―
Neola Medical AB
―